Nundina › Descubrir calendarios › Calendario de Aprobaciones de nuevos medicamentos de la FDA › FDA approves Emcitate (tiratricol)FDA approves Emcitate (tiratricol)28 de septiembre de 2026The FDA approved Emcitate (tiratricol), a drug from Rare Thyroid. Form: Tablet, For Suspension, Oral. Granted priority review, reserved for treatments that would be a significant improvement over what exists. Application NDA220963.Calendario de Aprobaciones de nuevos medicamentos de la FDAMás de este calendario